+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiovascular Devices Market Global Briefing 2018

  • ID: 4452254
  • Report
  • January 2018
  • Region: Global
  • 31 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • C.R. Bard Inc
  • Cardinal Health
  • Edwards Lifesciences
  • Johnson & Johnson
  • MORE
Cardiovascular devices are designed to diagnose, prevent, monitor and treat diseases related to the cardiovascular system, including heart diseases and related health problems.

Asia Pacific was the largest region in the cardiovascular devices market in 2017, accounting for around 32% market share. North America was the second largest region accounting for around 32% market share. Africa was the smallest region accounting for around 3% market share.

The Cardiovascular Devices Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular devices market.

Reasons to Purchase:
  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

The Cardiovascular Devices Market Global Briefing 2018 covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the cardiovascular devices market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the cardiovascular devices market and suggests approaches.

Scope:

Markets Covered: Cardiovascular Surgery Devices, Cardiac Rhythm Management (CRM) Devices, Interventional Cardiology Devices, Defibrillator Devices, Peripheral Vascular Devices, Prosthetic Heart Valve Device, Electrophysiology Devices, and Cardiac Assist Devices
Companies Mentioned: Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cardinal Health, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Edwards Lifesciences, B. Braun Melsungen AG and C.R. Bard, Inc.
Geographic Scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East and Africa.
Time Series: Five years historic and forecast.
Data: Market value in $ billions.
Data Segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • C.R. Bard Inc
  • Cardinal Health
  • Edwards Lifesciences
  • Johnson & Johnson
  • MORE
Cardiovascular Devices Market Characteristics
Cardiovascular Devices Market Historic Growth (2013 - 2017)
Cardiovascular Devices Market Forecast
Cardiovascular Devices Market Segmentation
Cardiovascular Devices Market Size, Split by Segments, 2017, $ Billion
Cardiovascular Surgery Devices
Cardiac Rhythm Management (CRM) Devices
Cardiac Assist Devices
Cardiovascular Devices Market Geography Regional and Country Comparison
Global Cardiovascular Devices Market, Split by Region, 2017
Global Cardiovascular Devices Market, Historic and Forecast Growth Rate, Split by Region, 2013 - 2021
Global Cardiovascular Devices Market, Split by Country, 2017
Global Cardiovascular Devices Market, Historic and Forecast Growth Rate, Split by Country, 2013 - 2021
Cardiovascular Devices Market Competitive Landscape
Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Cardiovascular Devices Market Key Mergers and Acquisitions
Abbott Laboratories Acquired St. Jude Medical
Becton, Dickinson & Co. Acquired Bard
Cardinal Health Acquired Cordis
Philips Acquired Spectranetics Corp
Medtronic Acquired Twelve, Inc
St. Jude Medical Acquired of CardioMEMS
Boston Scientific Acquired Interventional Business of Bayer AG
Medtronic Acquired CardioInsight Technologies
Cardiovascular Devices Market Trends and Strategies
Technological Innovations
Increasing Demand for Minimally-Invasive Cardiac Surgeries
Wearable Technology
Growing Demand For Total Artificial Heart (TAH)
3-D Printed Heart Replica
Appendix
NAICS Definitions of Industry Covered in this Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
About the Publisher

List of Figures
Figure 1: Global Cardiovascular Devices Market, Historic Market Size, 2013 - 2017, $ Billion
Figure 2: Global Cardiovascular Devices Market, Forecast Market Size, 2017 - 2021, $ Billion
Figure 3: Global Cardiovascular Devices Market, Split by Segments, 2017, $ Billion
Figure 4: Global Cardiovascular Devices Market, Split by Region, 2017, $ Billion
Figure 5: Global Cardiovascular Devices Market, Historic and Forecast Growth, Split by Region, 2013 - 2021
Figure 6: Global Cardiovascular Devices Market, Split by Country, 2017, $ Billion
Figure 7: Global Cardiovascular Devices Market, Historic and Forecast Growth Rate, Split by Country, 2013 - 2021
Figure 8: Global Cardiovascular Devices Market, Key Competitor Estimated Market Shares, 2017, Percentage(%)

List of Tables
Table 1: Global Cardiovascular Devices Market, Historic Market Size, 2013 - 2017, $ Billion
Table 2: Global Cardiovascular Devices Market, Forecast Market Size, 2017 - 2021, $ Billion
Table 3: Global Cardiovascular Devices Market, Split by Segments, 2017, $ Billion
Table 4: Global Cardiovascular Devices Market, Split by Region, 2017, $ Billion
Table 5: Global Cardiovascular Devices Market, Historic and Forecast Growth, Split by Region, 2013 - 2021
Table 6: Global Cardiovascular Devices Market, Split by Country, 2017, $ Billion
Table 7: Global Cardiovascular Devices Market, Historic and Forecast Growth Rate, Split by Country, 2013 - 2021
Table 8: Global Cardiovascular Devices Market, Key Competitor Estimated Market Shares, 2017, Percentage(%)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • C.R. Bard Inc
  • Cardinal Health
  • Edwards Lifesciences
  • Johnson & Johnson
  • MORE
Cardiovascular devices are designed to diagnose, prevent, monitor and treat diseases related to the cardiovascular system, including heart diseases and related health problems. They include arrhythmia detectors, noninvasive blood pressure measurement systems, diagnostic intravascular catheters, external cardiac compressors, coronary vascular physiologic simulation software devices, external programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary bypass defoamers, echocardiographs, vascular graft prostheses, electrocardiographs, defibrillators and others.

Asia Pacific was the largest region in the cardiovascular devices market in 2017, accounting for around 32% market share. North America was the second largest region accounting for around 32% market share. Africa was the smallest region accounting for around 3% market share.

Companies in the market are focusing on R&D. Areas of development include pacemakers, coronary stents, angioplasty products and implantable cardiac defibrillators. for instance, introduction of bio absorbable vascular stents in percutaneous coronary interventions is promising. in July 2016, the FDA approved the first fully absorbable stent, Absorb GT1 BVS manufactured by Abbott Vascular for coronary artery disease. It offers a new treatment option for patients undergoing angioplasty and opting for absorbable devices instead of metallic stents. in April 2016, FDA approved the world’s first leadless pacemaker, Micra Transcatheter Pacemaker System to treat heart rhythm disorders, which is manufactured by Medtronic Plc. This pacemaker can deliver percutaneously directly into the right ventricle through a minimally invasive approach, and does not require the use of wired leads in providing electrical connection between heart and pulse-generating devices.
Note: Product cover images may vary from those shown
5 of 5
  • Medtronic plc
  • St. Jude Medical
  • Boston Scientific Corporation
  • Cardinal Health
  • Abbott Laboratories
  • Terumo Corporation
  • Johnson & Johnson
  • Edwards Lifesciences
  • B. Braun Melsungen AG
  • C.R. Bard Inc
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll